News | PET-MRI | November 08, 2018

Researcher Awarded 2018 Hitachi Healthcare Americas/RSNA Grant

 

 

David Schultz, M.D., Ph.D.

David Schultz, M.D., Ph.D.

The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded the 2018 Hitachi Healthcare Americas/RSNA Research Seed Grant to David Shultz, M.D., Ph.D. This grant is made possible by Hitachi Healthcare Americas’ support of the RSNA R&E Foundation. The Hitachi Healthcare Americas/RSNA Research Seed Grant provides $40,000 for a one-year project to test hypotheses and obtain pilot data in preparation for major grant applications. David Shultz, M.D., Ph.D., Princess Margaret Cancer Centre, with scientific advisor Patrick VeitHaibach, M.D., will use FAZA-PET/MRI to identify hypoxic tumor in patients with localized high-risk sarcoma. Dr. Shultz and his team will also use pimonidazole, a molecular probe for hypoxia, to validate the FAZA results and further characterize the biologic features of hypoxic tumors. The ultimate goal of this work is to determine if hypoxia imaging with PET/MRI improves the management of sarcoma and to evaluate and characterize hypoxic mechanisms on a molecular level within clinical specimens. Through these efforts, they seek to improve the ability to treat patients with high-risk sarcoma. The RSNA R&E Foundation Board of Trustees approved funding for $4 million in radiology research and education grants this year, achieving a funding rate of 35 percent of grant applicants. “The R&E Foundation is grateful for Hitachi Healthcare Americas’ support of the 2018 grant recipients. This longstanding partnership and commitment is a vital component in ensuring research innovation and seeding the future of radiology,” said N. Reed Dunnick, M.D., chair of the R&E Foundation Board of Trustees. 

For more information: www.rsna.org

Related Content

Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with Guerb
FDA Clears Siemens Healthineers' Multix Impact Digital X-ray System
Technology | Digital Radiography (DR) | January 21, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Multix Impact, an affordably priced, floor-mounted digital...
Partners HealthCare Chooses Visage 7 for Enterprise Imaging
News | Enterprise Imaging | January 18, 2019
Visage Imaging Inc. announced the signing of Partners HealthCare, the largest health system in Massachusetts, for...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Philips Launches Azurion With FlexArm
Technology | Angiography | January 17, 2019
Philips announced the launch of Azurion with FlexArm, designed to enhance positioning flexibility for image-guided...
NewYork-Presbyterian Hospital Partners With Philips for Health IT and Clinical Informatics
News | Enterprise Imaging | January 16, 2019
Philips announced that NewYork-Presbyterian Hospital has chosen to implement the company’s IntelliSpace Enterprise...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Artificial Intelligence | January 15, 2019
ITN Contributing Editor Greg Freiherr offers an overview of...
Sponsored Content | Videos | Enterprise Imaging | January 14, 2019
ITN Contributing Editor Greg Freiherr offers an overview of enterprise